Skip to main content

Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

3.690 -0.100 (-2.64%)
Streaming Delayed Price Updated: 2:52 PM EST, Nov 13, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 7,724
Open 3.770
Bid (Size) 3.450 (100)
Ask (Size) 3.820 (100)
Prev. Close 3.790
Today's Range 3.560 - 3.770
52wk Range 1.001 - 7.000
Shares Outstanding 2,084,016,678
Dividend Yield N/A

Performance

YTD
-1.1%
-1.1%
1 Month
-22.0%
-22.0%
3 Month
-29.4%
-29.4%
6 Month
-2.6%
-2.6%
1 Year
+212.7%
+212.7%

More News

Read More

Frequently Asked Questions

Is Alterity Therapeutics Limited - American Depositary Shares publicly traded?
Yes, Alterity Therapeutics Limited - American Depositary Shares is publicly traded.
What exchange does Alterity Therapeutics Limited - American Depositary Shares trade on?
Alterity Therapeutics Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alterity Therapeutics Limited - American Depositary Shares?
The ticker symbol for Alterity Therapeutics Limited - American Depositary Shares is ATHE on the Nasdaq Stock Market
What is the current price of Alterity Therapeutics Limited - American Depositary Shares?
The current price of Alterity Therapeutics Limited - American Depositary Shares is 3.690
When was Alterity Therapeutics Limited - American Depositary Shares last traded?
The last trade of Alterity Therapeutics Limited - American Depositary Shares was at 11/13/25 02:52 PM ET
What is the market capitalization of Alterity Therapeutics Limited - American Depositary Shares?
The market capitalization of Alterity Therapeutics Limited - American Depositary Shares is 7.69B
How many shares of Alterity Therapeutics Limited - American Depositary Shares are outstanding?
Alterity Therapeutics Limited - American Depositary Shares has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.